Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

mRNA stability fine tunes gene expression in the developing cortex to control neurogenesis

Open access

Preprint — published as 10.1371/journal.pbio.3003031 · Paper page

Abstract

RNA expression levels are controlled by the complementary processes of synthesis and degradation. Although mis-regulation of RNA turnover is linked to neurodevelopmental disorders, how it contributes to cortical development is largely unknown. Here, we profile the RNA stability landscape of the cortex across development and demonstrate that control of stability by the CCR4-NOT complex is essential for corticogenesis in vivo . First, we use SLAM-seq to measure RNA half-lives transcriptome-wide across multiple stages of cortical development. We characterize cis -acting features associated with RNA stability and find that RNAs that are upregulated across development tend to be more stable, while downregulated RNAs are less stable. To probe how disruption of RNA turnover impacts cortical development, we assess developmental requirements of CNOT3, a core component of the CCR4-NOT deadenylase complex. Mutations in CNOT3 are associated with human neurodevelopmental disorders, however its role in cortical development is unknown. Conditional knockout of Cnot3 in neural progenitors and their progeny in the developing mouse cortex leads to severe microcephaly due to reduced neuron production and p53-dependent apoptosis. Collectively, our findings demonstrate that fine-tuned control of RNA turnover is crucial for brain development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2024.07.22.604643

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 The developmental landscape of cortical RNA stability. (A) Overview of cortical development showing RGCs generating neurons directly, or indirectly through IPs, with goals of this study schematized below. (B) Approach for SLAM-seq experiment, with relative cellular composition of the cortex at the 3 developmental stages used in this study (n = 3 biological replicates per stage). (C) Histograms showing distribution of RNA half-lives. (D, E) Venn diagrams for top 10% most and least stable transcripts identified at each stage. (F) CSC values for each of the 61 non-stop codons. (G) Half-lives of RNAs binned into quartiles based on percentage of optimal (positive CSC) codons. (H) Half-lives of RNAs with or without m6A. *** p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (G), Wilcoxon rank-sum test (H). Underlying data for this figure can be found in S1 Data. CSC, codon stabilization coefficient; IP, intermediate progenitor; RGC, radial glial cell.
Fig 1 The developmental landscape of cortical RNA stability. (A) Overview of cortical development showing RGCs generating neurons directly, or indirectly through IPs, with goals of this study schematized below. (B) Approach for SLAM-seq experiment, with relative cellular composition of the cortex at the 3 developmental stages used in this study (n = 3 biological replicates per stage). (C) Histograms showing distribution of RNA half-lives. (D, E) Venn diagrams for top 10% most and least stable transcripts identified at each stage. (F) CSC values for each of the 61 non-stop codons. (G) Half-lives of RNAs binned into quartiles based on percentage of optimal (positive CSC) codons. (H) Half-lives of RNAs with or without m6A. *** p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (G), Wilcoxon rank-sum test (H). Underlying data for this figure can be found in S1 Data. CSC, codon stabilization coefficient; IP, intermediate progenitor; RGC, radial glial cell.CC0 · PubMed Central
Fig 2 Dynamic patterns of mRNA half-lives across cortical development. (A) Heatmap showing z-score normalized half-lives for 294 significantly changing transcripts at E11.5, E14.5, and E16.5 (n = 3 biological replicates per stage). Numbers to the right indicate cluster labels. (B) Z-score normalized half-lives for transcripts found in the indicated clusters. *p < 0.05, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Underlying data for this figure can be found in S2 Data.
Fig 2 Dynamic patterns of mRNA half-lives across cortical development. (A) Heatmap showing z-score normalized half-lives for 294 significantly changing transcripts at E11.5, E14.5, and E16.5 (n = 3 biological replicates per stage). Numbers to the right indicate cluster labels. (B) Z-score normalized half-lives for transcripts found in the indicated clusters. *p < 0.05, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Underlying data for this figure can be found in S2 Data.CC0 · PubMed Central
Fig 3 Distinct stability profiles for developmentally regulated and cell type enriched mRNAs. (A, B) Volcano plots showing transcript expression changes at E14.5 compared to E11.5 (A), or E16.5 compared to E14.5 (B). n = 3 biological replicates per stage. (C, D) Half-lives of differentially expressed transcripts at the indicated developmental transitions. (E) Half-lives for a subset of transcripts enriched in either progenitors (n = 56) or neurons (n = 57). **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (C, D), Wilcoxon rank-sum test (E). Underlying data for this figure can be found in S3 Data.
Fig 3 Distinct stability profiles for developmentally regulated and cell type enriched mRNAs. (A, B) Volcano plots showing transcript expression changes at E14.5 compared to E11.5 (A), or E16.5 compared to E14.5 (B). n = 3 biological replicates per stage. (C, D) Half-lives of differentially expressed transcripts at the indicated developmental transitions. (E) Half-lives for a subset of transcripts enriched in either progenitors (n = 56) or neurons (n = 57). **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (C, D), Wilcoxon rank-sum test (E). Underlying data for this figure can be found in S3 Data.CC0 · PubMed Central
Fig 4 Cnot3 controls cerebral cortex size and neuronal number. (A) Schematic of CCR4-NOT complex with CNOT3 indicated in red. (B) cKO strategy using Emx1-Cre to target RGCs and their progeny, including IPs and neurons. (C) Western blot using whole cortex protein lysates from E12.5 control (ctrl), conditional heterozygous (cHet), or cKO embryos. Quantifications shown to the right (n = 4 embryos per genotype). (D) Whole mount images and coronal cross sections of E18.5 brains. Quantifications of cortex area and thickness shown to the right (n = 4 embryos per genotype). (E–H) Immunofluorescence for indicated neuronal markers in E18.5 cortical sections, with quantifications shown to the right. n = 3–5 embryos per genotype. *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 1 mm (D, top), 500 μm (D, bottom), 50 μm (E–H). Underlying data for this figure can be found in S4 Data. cKO, conditional knockout; IP, intermediate progenitor; RGC, radial glial cell.
Fig 4 Cnot3 controls cerebral cortex size and neuronal number. (A) Schematic of CCR4-NOT complex with CNOT3 indicated in red. (B) cKO strategy using Emx1-Cre to target RGCs and their progeny, including IPs and neurons. (C) Western blot using whole cortex protein lysates from E12.5 control (ctrl), conditional heterozygous (cHet), or cKO embryos. Quantifications shown to the right (n = 4 embryos per genotype). (D) Whole mount images and coronal cross sections of E18.5 brains. Quantifications of cortex area and thickness shown to the right (n = 4 embryos per genotype). (E–H) Immunofluorescence for indicated neuronal markers in E18.5 cortical sections, with quantifications shown to the right. n = 3–5 embryos per genotype. *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 1 mm (D, top), 500 μm (D, bottom), 50 μm (E–H). Underlying data for this figure can be found in S4 Data. cKO, conditional knockout; IP, intermediate progenitor; RGC, radial glial cell.CC0 · PubMed Central
Fig 5 Cnot3 is required for progenitor cell number and cell survival. (A) Immunofluorescence for SOX2 and TBR2 in E14.5 cortical sections, with quantifications shown in (B–D). n = 3–6 embryos per genotype. (E) Immunofluorescence for CC3 in E11.5 (top) and E12.5 (bottom) cortical sections. (F) Quantification of CC3+ cells from genotypes in (E) (n = 3–5 embryos per condition). (G) Immunofluorescence for CC3 and TUJ1 in an E12.5 cKO cortical section. (H) Quantification of percentage of CC3+ cells that were either TUJ1+ or TUJ1- in E12.5 cKO cortices (n = 3 embryos). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 50 μm. Underlying data for this figure can be found in S5 Data. cKO, conditional knockout; CC3, cleaved caspase 3.
Fig 5 Cnot3 is required for progenitor cell number and cell survival. (A) Immunofluorescence for SOX2 and TBR2 in E14.5 cortical sections, with quantifications shown in (B–D). n = 3–6 embryos per genotype. (E) Immunofluorescence for CC3 in E11.5 (top) and E12.5 (bottom) cortical sections. (F) Quantification of CC3+ cells from genotypes in (E) (n = 3–5 embryos per condition). (G) Immunofluorescence for CC3 and TUJ1 in an E12.5 cKO cortical section. (H) Quantification of percentage of CC3+ cells that were either TUJ1+ or TUJ1- in E12.5 cKO cortices (n = 3 embryos). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 50 μm. Underlying data for this figure can be found in S5 Data. cKO, conditional knockout; CC3, cleaved caspase 3.CC0 · PubMed Central
Fig 6 p53-dependent apoptosis controls upper but not deep layer neurons. (A) Immunofluorescence for p53 in E12.5 cortical sections. (B) Whole mount images and coronal cross sections of E18.5 brains. (C, D) Quantifications of cortex area and thickness (n = 3–6 embryos per genotype). (E–H) Immunofluorescence for indicated neuronal markers in E18.5 cortical sections, with quantifications shown to the right (n = 3–6 embryos per genotype). (I) Immunofluorescence for SOX2 and TBR2 in E14.5 cortical sections. (J–L) Quantification of cortical thickness, SOX2, and TBR2 at E14.5 (n = 2–7 embryos per genotype). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 1 mm (B, top), 500 μm (B, bottom), 50 μm (A, E–I). Underlying data for this figure can be found in S6 Data.
Fig 6 p53-dependent apoptosis controls upper but not deep layer neurons. (A) Immunofluorescence for p53 in E12.5 cortical sections. (B) Whole mount images and coronal cross sections of E18.5 brains. (C, D) Quantifications of cortex area and thickness (n = 3–6 embryos per genotype). (E–H) Immunofluorescence for indicated neuronal markers in E18.5 cortical sections, with quantifications shown to the right (n = 3–6 embryos per genotype). (I) Immunofluorescence for SOX2 and TBR2 in E14.5 cortical sections. (J–L) Quantification of cortical thickness, SOX2, and TBR2 at E14.5 (n = 2–7 embryos per genotype). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test. Error bars represent standard deviation. Scale bars: 1 mm (B, top), 500 μm (B, bottom), 50 μm (A, E–I). Underlying data for this figure can be found in S6 Data.CC0 · PubMed Central
Fig 7 Cnot3 controls neural cell fate by modulating progenitor cell cycle duration and neurogenic divisions. (A) Top, schematic of experimental approach for semi-cumulative labeling at E12.5. Bottom, immunofluorescence for the indicated markers in E12.5 cortical sections. (B) Quantification of total cell cycle duration (Tc), S-phase (Ts) (n = 4 embryos per genotype). (C) Quantification of the ratio between S-phase and total cell cycle (Ts/Tc). (D) Top, schematic of experimental approach for live imaging of E12.5 primary progenitor divisions. Bottom, DIC images at the beginning (t = 0 h) and end (t = 20 h) of the live imaging session and immunofluorescence after fixation for SOX2, TBR2, and TUJ1 showing representative proliferative and neurogenic divisions (n: Ctrl = 4 brains (446 divisions), cHet = 3 brains (331 divisions), cKO = 3 brains (350 divisions)). (E) Quantification of cell divisions: Proliferative (2 SOX2+TUJ1-, 2TBR2+TUJ1-, or one of each); Asymmetric neurogenic (1 SOX2+TUJ1- or TBR2+TUJ1- and 1 TUJ1+); Symmetric neurogenic (2 TUJ1+). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (B, C). Chi-squared test with Bonferroni post hoc adjusted p-values (E). Error bars represent standard deviation. Scale bars: 50 μm (A), 10 μm (D). Underlying data for this figure can be found in S7 Data. cKO, conditional knockout.
Fig 7 Cnot3 controls neural cell fate by modulating progenitor cell cycle duration and neurogenic divisions. (A) Top, schematic of experimental approach for semi-cumulative labeling at E12.5. Bottom, immunofluorescence for the indicated markers in E12.5 cortical sections. (B) Quantification of total cell cycle duration (Tc), S-phase (Ts) (n = 4 embryos per genotype). (C) Quantification of the ratio between S-phase and total cell cycle (Ts/Tc). (D) Top, schematic of experimental approach for live imaging of E12.5 primary progenitor divisions. Bottom, DIC images at the beginning (t = 0 h) and end (t = 20 h) of the live imaging session and immunofluorescence after fixation for SOX2, TBR2, and TUJ1 showing representative proliferative and neurogenic divisions (n: Ctrl = 4 brains (446 divisions), cHet = 3 brains (331 divisions), cKO = 3 brains (350 divisions)). (E) Quantification of cell divisions: Proliferative (2 SOX2+TUJ1-, 2TBR2+TUJ1-, or one of each); Asymmetric neurogenic (1 SOX2+TUJ1- or TBR2+TUJ1- and 1 TUJ1+); Symmetric neurogenic (2 TUJ1+). *p < 0.05, **p < 0.01, ***p < 0.001. One-way ANOVA with Tukey’s HSD post hoc test (B, C). Chi-squared test with Bonferroni post hoc adjusted p-values (E). Error bars represent standard deviation. Scale bars: 50 μm (A), 10 μm (D). Underlying data for this figure can be found in S7 Data. cKO, conditional knockout.CC0 · PubMed Central
Fig 8 Transcriptomic and stability analysis reveals molecular targets of CNOT3. (A) Volcano plots showing differentially expressed transcripts in cKO (left) and dcKO (right) cortices versus control at E12.5 (n = 3 embryos per genotype). (B) Expression of p53 target genes as measured by RNA-seq (left) or qPCR (right). (C) Venn diagram showing overlap between differentially expressed genes in cKO and dcKO cortices. (D) Log10(expression) of cKO/dcKO shared up-regulated genes (Up; n = 431), shared down-regulated genes (Down, n = 289), and all other genes (NS, n = 13,089) in Ctrl cortices. (E) Percentage of optimal codons (CSC > 0) for shared differentially expressed genes. (F) Log2(fold change) in dcKO versus control cortices for all genes, binned into quartiles based on percentage of optimal codons. (G) Left, schematic of experimental approach for transcriptional shutoff of E12.5 primary cultures with actinomycin D (Act D). Right, half-lives of the indicated transcripts determined by RT-qPCR (n = 4 embryos per genotype). *p < 0.05, **p < 0.01, ***p < 0.001. Adjusted p-values from DESeq2 (B (RNA-seq)). One-way ANOVA with Tukey’s HSD post hoc test (B (qPCR), D–F), Welch’s two-sample t test (G). Error bars represent standard deviation. Underlying data for this Figure can be found in S8 Data. cKO, conditional knockout; CSC, codon stabilization coefficient; dcKO, double conditional knockout.
Fig 8 Transcriptomic and stability analysis reveals molecular targets of CNOT3. (A) Volcano plots showing differentially expressed transcripts in cKO (left) and dcKO (right) cortices versus control at E12.5 (n = 3 embryos per genotype). (B) Expression of p53 target genes as measured by RNA-seq (left) or qPCR (right). (C) Venn diagram showing overlap between differentially expressed genes in cKO and dcKO cortices. (D) Log10(expression) of cKO/dcKO shared up-regulated genes (Up; n = 431), shared down-regulated genes (Down, n = 289), and all other genes (NS, n = 13,089) in Ctrl cortices. (E) Percentage of optimal codons (CSC > 0) for shared differentially expressed genes. (F) Log2(fold change) in dcKO versus control cortices for all genes, binned into quartiles based on percentage of optimal codons. (G) Left, schematic of experimental approach for transcriptional shutoff of E12.5 primary cultures with actinomycin D (Act D). Right, half-lives of the indicated transcripts determined by RT-qPCR (n = 4 embryos per genotype). *p < 0.05, **p < 0.01, ***p < 0.001. Adjusted p-values from DESeq2 (B (RNA-seq)). One-way ANOVA with Tukey’s HSD post hoc test (B (qPCR), D–F), Welch’s two-sample t test (G). Error bars represent standard deviation. Underlying data for this Figure can be found in S8 Data. cKO, conditional knockout; CSC, codon stabilization coefficient; dcKO, double conditional knockout.CC0 · PubMed Central
Fig 9 Models for relationship between RNA turnover and gene expression, and the role of Cnot3 in cortical development. (A) Transcripts that are down-regulated across development are relatively unstable, while those that are up-regulated across development are relatively stable. For the majority of transcripts, RNA half-lives are static across development. Cortical development in WT (B) and Cnot3 cKO embryos (C). Loss of Cnot3 impacts development by p53-dependent and p53-independent mechanisms leading to apoptosis of progenitors and neurons, reduced neurogenic divisions, and longer cell cycle duration. Our data suggest that apoptosis is especially relevant for reduced number of upper layer neurons. cKO, conditional knockout.
Fig 9 Models for relationship between RNA turnover and gene expression, and the role of Cnot3 in cortical development. (A) Transcripts that are down-regulated across development are relatively unstable, while those that are up-regulated across development are relatively stable. For the majority of transcripts, RNA half-lives are static across development. Cortical development in WT (B) and Cnot3 cKO embryos (C). Loss of Cnot3 impacts development by p53-dependent and p53-independent mechanisms leading to apoptosis of progenitors and neurons, reduced neurogenic divisions, and longer cell cycle duration. Our data suggest that apoptosis is especially relevant for reduced number of upper layer neurons. cKO, conditional knockout.CC0 · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 85

  1. 2023, Specific recognition and ubiquitination of translating ribosomes by mammalian CCR4-NOT, Nat Struct Mol Biol, 30, 1314, 10.1038/s41594-023-01075-8 · DOI
  2. 10.1038/s41598-017-17204-5 · DOI · Paper page
  3. 10.1126/science.aax3072 · DOI · Paper page
  4. 10.15252/embj.201694699 · DOI · Paper page
  5. 10.1038/nsmb.2681 · DOI
  6. 10.1016/j.celrep.2012.05.017 · DOI · Paper page
  7. 10.1016/j.cub.2015.01.041 · DOI · Paper page
  8. 10.1016/j.celrep.2018.07.039 · DOI
  9. 2015, Dynamic regulation of mRNA decay during neural development, Neural Dev, 10, 11, 10.1186/s13064-015-0038-6 · DOI
  10. Buschauer R , Matsuo Y , Sugiyama T , Chen YH , Alhusaini N , Sweet T , Ikeuchi K , Cheng J , Matsuki Y , Nobuta R et al. 2020. The Ccr4-Not complex monitors the translating ribosome for codon optimality. Science 368. · DOI · Paper page
  11. 10.1073/pnas.83.6.1670 · DOI · Paper page
  12. Chen Q , Malki S , Xu X , Bennett B , Lackford BL , Kirsanov O , Geyer CB , Hu G . 2023. Cnot3 is required for male germ cell development and spermatogonial stem cell maintenance. bioRxiv: 2023.2010.2013.562256. · doi:10.1101/2023.10.13.562256
  13. 2016, The Ccr4-Not complex is a key regulator of eukaryotic gene expression, Wiley Interdiscip Rev RNA, 7, 438, 10.1002/wrna.1332 · DOI · Paper page
  14. 2024, Making Ramon y Cajal proud: Development of cell identity and diversity in the cerebral cortex, Neuron, 112, 2091, 10.1016/j.neuron.2024.04.021 · DOI
  15. 10.1038/s41586-021-03670-5 · DOI · Paper page
  16. 10.1093/bioinformatics/bts635 · DOI · Paper page
  17. 10.7554/eLife.10288 · DOI
  18. 10.1093/bioinformatics/bti525 · DOI · Paper page
  19. 10.1093/nar/gkab1185 · DOI
  20. 10.1073/pnas.1209647109 · DOI · Paper page
  21. 10.1038/s41467-024-47290-9 · DOI
  22. 10.1371/journal.pone.0228730 · DOI · Paper page
  23. 10.1002/dvg.20256 · DOI · Paper page
  24. 10.1523/JNEUROSCI.22-15-06309.2002 · DOI · Paper page
  25. 10.1038/nrn3586 · DOI · Paper page
  26. 10.1242/dev.005447 · DOI · Paper page
  27. 2024, Dictionary learning for integrative, multimodal and scalable single-cell analysis, Nat Biotechnol, 42, 293, 10.1038/s41587-023-01767-y · DOI · Paper page
  28. 10.1038/nmeth.4435 · DOI · Paper page
  29. 10.1126/science.1074560 · DOI · Paper page
  30. 10.7554/eLife.78203 · DOI
  31. 10.1016/j.conb.2020.10.001 · DOI
  32. 10.1038/mp.2017.173 · DOI
  33. 10.1084/jem.20150384 · DOI
  34. 2018, Nonsense-mediated RNA decay in the brain: emerging modulator of neural development and disease, Nat Rev Neurosci, 19, 715, 10.1038/s41583-018-0079-z · DOI
  35. 10.1038/s41594-020-0465-x · DOI · Paper page
  36. 10.1016/j.ajhg.2019.03.017 · DOI
  37. 2021, NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome, Genome Biol, 22, 317, 10.1186/s13059-021-02530-9 · DOI
  38. 10.1242/dev.069963 · DOI · Paper page
  39. 2020, Molecular Mechanisms Driving mRNA Degradation by m(6)A Modification, Trends Genet, 36, 177, 10.1016/j.tig.2019.12.007 · DOI · Paper page
  40. 2018, RNA on the brain: emerging layers of post-transcriptional regulation in cerebral cortex development, Wiley Interdiscip Rev Dev Biol, 7, 10.1002
  41. 10.1093/bioinformatics/btt656 · DOI · Paper page
  42. 2022, Bio-Strings: A Relational Database Data-Type for Dealing with Large Biosequences, BioTech (Basel), 11, 31
  43. 2024, Epistatic interactions between NMD and TRP53 control progenitor cell maintenance and brain size, Neuron, 112, 2157, 10.1016/j.neuron.2024.04.006 · DOI
  44. 10.1093/hmg/ddy350 · DOI
  45. 10.1016/j.celrep.2014.01.028 · DOI · Paper page
  46. 10.1186/s13059-014-0550-8 · DOI · Paper page
  47. 2023, The exon junction complex component EIF4A3 is essential for mouse and human cortical progenitor mitosis and neurogenesis, Development, 150, dev201619, 10.1242/dev.201619 · DOI
  48. 2023, A novel pathogenic variant in CNOT3 causing neurodevelopmental delay and epilepsy, Seizure, 107, 104, 10.1016/j.seizure.2023.03.022 · DOI
  49. 10.1371/journal.pgen.1006282 · DOI
  50. 10.1101/gad.14.8.994 · DOI · Paper page
  51. 10.1038/s41431-019-0413-6 · DOI
  52. 10.1101/cshperspect.a034728 · DOI · Paper page
  53. 2020, Inherited cases of CNOT3-associated intellectual developmental disorder with speech delay, autism, and dysmorphic facies, Clin Genet, 98, 408, 10.1111/cge.13819 · DOI
  54. 10.1038/msb.2010.112 · DOI · Paper page
  55. 2019, Acute Lengthening of Progenitor Mitosis Influences Progeny Fate during Cortical Development in vivo, Dev Neurosci, 41, 300, 10.1159/000507113 · DOI
  56. 10.1016/j.neuron.2014.12.024 · DOI · Paper page
  57. 10.1261/rna.073239.119 · DOI
  58. 10.1093/bioinformatics/btu333 · DOI · Paper page
  59. 2022, Roles of mRNA poly(A) tails in regulation of eukaryotic gene expression, Nat Rev Mol Cell Biol, 23, 93, 10.1038/s41580-021-00417-y · DOI · Paper page
  60. 10.1016/j.neuron.2015.12.007 · DOI · Paper page
  61. 10.1016/j.cell.2015.02.029 · DOI · Paper page
  62. 2021, Co-Occurring Heterozygous CNOT3 and SMAD6 Truncating Variants: Unusual Presentation and Refinement of the IDDSADF Phenotype, Genes (Basel), 12, 1009, 10.3390/genes12071009 · DOI
  63. 10.1016/j.ydbio.2006.08.035 · DOI · Paper page
  64. 10.1038/s41467-019-11094-z · DOI
  65. 10.1242/dev.129.20.4843 · DOI · Paper page
  66. 2019, CNOT3 targets negative cell cycle regulators in non-small cell lung cancer development, Oncogene, 38, 2580, 10.1038/s41388-018-0603-7 · DOI
  67. 10.1016/j.celrep.2016.10.066 · DOI
  68. 10.1016/j.devcel.2007.11.014 · DOI · Paper page
  69. 10.1016/j.bbrc.2012.02.007 · DOI
  70. 10.1523/JNEUROSCI.15-09-06046.1995 · DOI · Paper page
  71. 10.1038/ng2100 · DOI · Paper page
  72. 10.1126/science.aav2522 · DOI · Paper page
  73. 10.1186/gb-2010-11-9-r93 · DOI
  74. 10.1242/dev.188276 · DOI
  75. 2021, The regulation of cortical neurogenesis, Curr Top Dev Biol, 142, 1, 10.1016/bs.ctdb.2020.10.003 · DOI
  76. 10.1016/j.ajhg.2020.05.017 · DOI
  77. 10.1016/j.molcel.2018.05.033 · DOI · Paper page
  78. 10.7554/eLife.45396 · DOI · Paper page
  79. Yamaguchi T , Suzuki T , Sato T , Takahashi A , Watanabe H , Kadowaki A , Natsui M , Inagaki H , Arakawa S , Nakaoka S et al. 2018. The CCR4-NOT deadenylase complex controls Atg7-dependent cell death and heart function. Sci Signal 11. · DOI
  80. 10.1016/j.cell.2017.09.003 · DOI · Paper page
  81. 10.1016/S1097-2765(03)00179-5 · DOI · Paper page
  82. 2023, Clinical features of CNOT3-associated neurodevelopmental disorder in three Chinese patients, Neurogenetics, 24, 129, 10.1007/s10048-023-00713-z · DOI
  83. 10.1002/stem.1070 · DOI
  84. 2016, CNOT3-Dependent mRNA Deadenylation Safeguards the Pluripotent State, Stem Cell Reports, 7, 897, 10.1016/j.stemcr.2016.09.007 · DOI
  85. 2017, Cnot3 enhances human embryonic cardiomyocyte proliferation by promoting cell cycle inhibitor mRNA degradation, Sci Rep, 7, 1500, 10.1038/s41598-017-01628-0 · DOI

Metadata

Authors
Serdar, L. D., Egol, J. R., Lackford, B., Bennett, B. D., Hu, G., & Silver, D. L.
Affiliations
  • Duke Medical Center (US)
  • National Institute of Environmental Health Sciences (US)
  • Duke University (US)
Corresponding author
Silver, Debra L.
Venue
PLoS Biology
Publisher
openRxiv
Published
2024-07-22
Volume
23
Issue
2
Pages
e3003031-e3003031
ISSN
1544-9173 (ISSN-L)
OpenAlex
W4407199710
Cited by
14
References
1
Citations by year
2026: 8 · 2025: 6
FWCI
4.21
Type
journal article
Language
en
Open access
Licence
public-domain
Locations
  • PLoS Biology (publishedVersion, public-domain)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (R01MH132089)
  • National Institute of Neurological Disorders and Stroke (R01NS083897, R01NS110388, R21NS128374, R21NS098176, R01NS120667, R37NS110388)
  • National Institute of Environmental Health Sciences (Z01ES102745, ZIAES102745)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD107972)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
mRNA stability, RNA turnover, RNA half-life, cortical development, neurogenesis, CNOT3, microcephaly, p53-dependent apoptosis, neural progenitor cells, cell fate specification, cell cycle genes, neurodevelopmental disorders, SLAM-seq
MeSH terms
Animals, Cerebral Cortex, Microcephaly, RNA, Messenger, Transcription Factors, Apoptosis, Mice, Knockout, Gene Expression Regulation, Developmental, RNA Stability, Mice, Neurogenesis, Neural Stem Cells, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.